» Articles » PMID: 12695556

Detection of the Human Organic Anion Transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in Liver and Hepatocellular Carcinoma

Overview
Journal Lab Invest
Specialty Pathology
Date 2003 Apr 16
PMID 12695556
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Transport proteins mediating the selective uptake of organic anions into human hepatocytes include the organic anion transporters SLC21A6 (also termed OATP2, OATP-C, or LST-1) and SLC21A8 (OATP8). Both transporters are localized to the basolateral membrane of human hepatocytes. Because of the importance of these transporters for hepatobiliary elimination, including the removal of bilirubin and its conjugates from the blood circulation, we have generated monoclonal antibodies for studies on the expression and localization of these transport proteins. We describe two antibodies, designated monoclonal antibody MDQ (mMDQ) and monoclonal antibody ESL (mESL), directed against the amino terminus and the carboxyl terminus of human SLC21A6, respectively. Both antibodies have been characterized by immunoblot analysis, immunoprecipitation, and immunofluorescence microscopy. While mESL reacted specifically with SLC21A6, mMDQ detects both SLC21A6 and SLC21A8. Neither of the two antibodies reacted with other human, or with dog, rat, or mouse liver SLC21A family members. Antibody mMDQ may be used for the simultaneous detection of SLC21A6 and SLC21A8 in immunoblotting because of its immunoreactivity with both molecules and because of the different molecular masses of both glycosylated proteins in human hepatocytes. This is exemplified in hepatocellular carcinomas where SLC21A6 and SLC21A8 were differentially synthesized and showed an irregular staining pattern. Both transport proteins have not been detected in human hepatoma HepG2 cells. In routine paraffin sections, 10 of 12 hepatocellular carcinomas were focally positive with antibody mMDQ. In contrast, cholangiocarcinomas and liver metastases of colorectal and pancreatic adenocarcinoma were negative without exception. This suggests the usefulness of SLC21A6/SLC21A8 within a panel of tumor markers for hepatocellular carcinomas. Moreover, both antibodies should be useful in studies on the expression and localization of two important uptake transporters of human hepatocytes under physiologic and pathophysiologic conditions.

Citing Articles

Transcriptional Regulation of Liver-Type OATP1B3 (Lt-OATP1B3) and Cancer-Type OATP1B3 (Ct-OATP1B3) Studied in Hepatocyte-Derived and Colon Cancer-Derived Cell Lines.

Haberkorn B, Lowen D, Meier L, Fromm M, Konig J Pharmaceutics. 2023; 15(3).

PMID: 36986600 PMC: 10051083. DOI: 10.3390/pharmaceutics15030738.


New approach methodologies: A quantitative in vitro to in vivo extrapolation case study with PFASs.

Fragki S, Louisse J, Bokkers B, Luijten M, Peijnenburg A, Rijkers D Food Chem Toxicol. 2022; 172:113559.

PMID: 36535450 PMC: 9890272. DOI: 10.1016/j.fct.2022.113559.


May phytophenolics alleviate aflatoxins-induced health challenges? A holistic insight on current landscape and future prospects.

Rasouli H, Nayeri F, Khodarahmi R Front Nutr. 2022; 9:981984.

PMID: 36386916 PMC: 9649842. DOI: 10.3389/fnut.2022.981984.


Effect of type 2 diabetes on Gd-EOB-DTPA uptake into liver parenchyma: replication study in human subjects.

Kumasaka S, Seki Y, Kumasaka Y, Tsushima Y Abdom Radiol (NY). 2021; 46(10):4682-4688.

PMID: 34164726 DOI: 10.1007/s00261-021-03184-8.


How Dysregulated Ion Channels and Transporters Take a Hand in Esophageal, Liver, and Colorectal Cancer.

Stock C Rev Physiol Biochem Pharmacol. 2020; 181:129-222.

PMID: 32875386 DOI: 10.1007/112_2020_41.